Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Nipro Medical announces US launch of Elisio Polynephron dialyzer

Nipro Medical has launched its Elisio Polynephron dialyzer, designed for the renal market, targeting those involved in care and procedures for kidney disease and dialysis.

Equipped with the new Polynephron high-flux membrane, the new dialyzer delivers outstanding biocompatibility, hemocompatibility, and solute-removal performance. This high-flux membrane provides highest number of fibers where each fiber acts like a nephron.

A 3D chemical structure affords an ideal mixture of hydrophilic and hydrophobic domains, while reducing membrane fouling and maximizing membrane performance.

The single use, high-flux, hollow-fiber dialyzer incorporates advanced pore-spinning technology that allows the creation of more homogenous pore sizes for optimizing sieving properties.

Ripple structure of Elisio’s fiber creates less dialysate channeling – promoting better diffusive transport while enhancing small molecule clearances, and reducing the risk of fiber leakage.

Smooth polyurethane cut surface of the device helps reduce the risk of blood cell damage and an improved header shape reduces channeling at the blood side. The redesigned permanent caps eliminate the possibility of unexpected removal or reuse.

Nipro North America senior vice president Joe Dawson noted nipro dialyzers have been the preferred product for dialysis around the globe for the past 30 years.

"The introduction of the Elisio dialyzer builds on our strategy of becoming a complete and cost-effective dialysis solutions leader, offering blood tubing lines, fistulas needles, and now dialyzers to our dialysis market partners in the US market. Elisio is designed to deliver an elevated benefits platform to the market, especially in clearance performance of small to middle molecules, and it delivers on these objectives.

"Both in-vitro and in-vivo testing have demonstrated the superior clearance performance of the Elisio dialyzer for both small and middle molecules. In addition, clinicians reported excellent performance with regard to myglobin and B2 microglobulin, and excellent biocompatibility on WBC and C5a.

"Innovative features that deliver better dialysis patient outcomes are what Nipro has been delivering for more than 30 years. The Elisio dialyzer builds on this performance promise," Dawson added.

The Elisio Polynephron dialyzer, which is available in sizes from 90H to 250H, has obtained 510(k) approval from the US Food and Drug Administration.